- Home
- GV vs PPBT Comparison
GV vs PPBT Comparison
Compare GV & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GV | PPBT |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 4.4M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GV | PPBT |
|---|---|---|
| Price | $0.31 | $2.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | ★ 2.8M | 31.6K |
| Earning Date | 08-14-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $0.41 |
| 52 Week High | $4.18 | $5.18 |
Technical Indicators
Market Signals| Indicator | GV | PPBT |
|---|---|---|
| Relative Strength Index (RSI) | 57.58 | 32.32 |
| Support Level | $0.17 | $0.57 |
| Resistance Level | $0.51 | $4.39 |
| Average True Range (ATR) | 0.06 | 0.32 |
| MACD | 0.02 | -0.16 |
| Stochastic Oscillator | 89.20 | 17.53 |
Price Performance
Historical ComparisonAbout GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.